CADE probes drugmaker for price hike
Brazil’s public prosecutor has complained against Gilead Sciences to the country’s competition enforcer, reportedly about the drugmaker raising the price of a hepatitis C medication by more than 1400%.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10